Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants.
about
Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated SignalingPretreatment assessment of hepatocellular carcinoma: expert consensus statement.Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experienceFibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin.Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinomaClinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea.Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.Radiofrequency ablation of cancerLiver transplantation().GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinomaSpecific mutations of hepatitis B virus in plasma predict liver cancer development.Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.Imaging findings and transcatheter arterial chemoembolization of hepatic malignancy with right atrial embolus in 46 patients.Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma.Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes.Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.The role of Med19 in the proliferation and tumorigenesis of human hepatocellular carcinoma cells.Combined hepatocellular cholangiocarcinoma: a case report and review of literature.Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinomaLung mass in a 28-year-old male: a case report of a rare tumor.Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10.Cholangiocarcinoma in liver cirrhosis.Utility of Cytokeratin7 Immunocytochemistry in the Cytopathological Diagnosis of Fibrolamellar Hepatocellular Carcinoma.Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinomaLiver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America
P2860
Q27487140-CA387FC1-9909-4339-97F6-CA328EEBA024Q30432108-9B9AC6EB-1854-4506-BD94-1815DB47B173Q30602517-9FCC3073-A272-4F78-978A-17D27E2EFD32Q33402113-C9446C99-8C34-4BEB-B6AB-3680CEAD70ECQ33695465-E6C981DF-FFD6-4B58-856A-9E5725A399C7Q33866286-E6D4452B-D2BE-43E4-9E4D-85B6EE921C1EQ35006160-2ADC9178-C3E1-4595-A8C6-D16CD5497321Q35176302-5B579EC0-7B5C-49E6-956A-0ED0943464A5Q35207762-5E22515B-F7D7-4C91-90EF-37672328AF66Q35895377-D86F49C6-7781-4B0D-B81A-8EEA94C5CCE3Q36340199-DB3692C9-BCEF-40AD-9EE4-C1466B7B2113Q36545246-14A45190-807B-48D0-9BFA-EB876E6791A8Q37074286-913018D8-16D4-442E-8D44-0C1352F42550Q37096406-4CCC9D7D-6743-440B-8DF3-D089C19133CFQ37277461-E09AC4DC-47F6-4882-A116-BAD904EB036AQ37305597-C32D9139-063C-4F3A-90C3-4A12390AA0E8Q37312846-D8146DAC-5DCD-40BA-9743-CCE4E132BA55Q37670887-9F7D5971-B9A8-4942-9DA5-A1762BDB4B51Q37675494-DCB4CE49-F16A-46A9-A208-C8EB4D71D77AQ37728861-D1883FB9-8DFB-4FF4-977B-BBBFAC155AADQ38080486-D08D6122-F05C-4158-8779-5DCFAB8F91DEQ38670649-1CE56D97-7A3E-4DB5-86C0-E4945A7B2018Q39868384-B7D2C4EF-8E65-4C05-923B-4794477E1D56Q40340244-79DCF9D0-1708-402F-A4C0-A3A3AEF50AB3Q42844321-65812236-9C52-4E8B-9F60-08A29D1FEE6CQ53658023-83084A25-4111-4932-B097-D08B3025B982Q55000321-35DDE6DB-F1C7-4FD7-9DAD-C7918ABB1C1EQ57112805-875D478C-C163-4A7C-B543-FBD42829A7A0Q57724627-CB46714B-D297-4E45-AE13-D409AE881521
P2860
Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@ast
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@en
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@nl
type
label
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@ast
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@en
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@nl
prefLabel
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@ast
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@en
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@nl
P2860
P1476
Natural history of hepatocellu ...... o-cholangiocarcinoma variants.
@en
P2093
Kunio Okuda
P2860
P304
P356
10.1046/J.1440-1746.2002.02734.X
P577
2002-04-01T00:00:00Z